Amanda Winters, MD, PhD
Pediatric Hematology / Oncology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
My clinical focus is in the treatment of children with cancer, in particular leukemias and conditions that may lead to leukemias such as inherited bone marrow failure syndromes or myelodysplastic syndromes (MDS).
Care Philosophy
I believe in providing the most evidence-based and compassionate care possible to my patients and their families. A diagnosis of cancer is one of the worst experiences of a family's life, and making it easier or more manageable to the child and his/her family in some small way is as important to me as providing physical healing. I and my colleagues also strive to treat patients with the most up-to-date in cancer therapies available.
Specialties
- Pediatric Hematology / Oncology ( 2019 )
Conditions & Treatments
-
Cancers
Aplastic Anemia, Chemotherapy, Leukemia (Childhood), Lymphoma, Myelodysplastic Syndrome, Pediatric Cancer
Interests & Activities
Personal Interests
In addition to clinical care of patients, which is most important to me, I am interested in research that brings newer and better drugs into the care of children with cancer. I am also passionate about medical education.
Education & Training
Medical Schools
MD, Tulane University School of Medicine (2011)
Undergraduate Schools
BS, University of Southern Mississippi (MS) (2004)
Graduate Schools
PhD, Tulane University School of Medicine (2011)
Internships
Cincinnati Children's Hospital Medical Center Program (2012)
Residency Program
Cincinnati Children's Hospital Medical Center Program (2014)
Fellowships
University of Colorado (Children's Hospital Colorado) Program (2017)
Professional Memberships
American Academy of Pediatrics, Member
American Board of Pediatrics, Board-Certified, General Pediatrics
American Society of Hematology, Member
American Society of Pediatric Hematology/Oncology, Member
Research & Grants
Grants
Young Investigator Award (2018)
Morgan Adams Foundation Research Grant (2020)
K08 (2023)
Research Interests for Patients
I perform in-laboratory testing of new drugs that have been developed for acute myeloid leukemia (AML). These drugs are being tested in clinical trials in adults, and may be useful for children with AML as well. I'm also trying to develop more sensitive methods to detect molecular disease when it is not otherwise detectable after therapy, so we can more accurately know how much therapy is needed for individual patients.
information for referring providers
Referral Contact Phone
(720) 777-6740
Clinical Interests for Referring Providers
Pediatric Hematology/Oncology Subspecialty interest in Leukemias, Acute Myeloid Leukemia, Leukemia Predisposition Syndromes, Myelodysplastic Syndromes (MDS)
Research Interest for Referring Providers
I am investigating targeted therapies for pediatric AML in the pre-clinical setting, including immunotherapies. In addition, I am developing droplet digital PCR assays as an alternative means to measure minimal residual disease in patients with AML.